Email updates

Keep up to date with the latest news and content from BMC Cancer and BioMed Central.

Open Access Email this article to a friend

Targeting of CD34+CD38- cells using Gemtuzumab ozogamicin (Mylotarg) in combination with tipifarnib (Zarnestra) in acute Myeloid Leukaemia

Mays Jawad, Ning Yu, Claire Seedhouse*, Karuna Tandon, Nigel H Russell and Monica Pallis

BMC Cancer 2012, 12:431  doi:10.1186/1471-2407-12-431

Fields marked * are required


Multiple email addresses should be separated with commas or semicolons.
How can I ensure that I receive BMC Cancer's emails?